Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata: In vivo effects in rodent brain

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 1, 2004, Pages 138-152

  Pascual, Isel ^a   Gil Parrado, Shirley ^a   Cisneros, Miguel ^b   Joseph Bravo, Patricia ^b   Díaz, Joaquín ^a   Possani, Lourival D ^b   Charli, Jean Louis ^b   Chávez, María ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Adenohypophysis; Marine invertebrate; Metallo peptidase; Spinal cord; TRH

Indexed keywords

2 DIETHYLAMINOETHANOL; 5 OXOPROLYL PEPTIDASE; ASPARTIC PROTEINASE; BROMELAIN; CARBOXYPEPTIDASE A; CHYMOTRYPSIN; COLLAGENASE; CYSTEINE PROTEINASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; ELASTASE; GELATINASE; MEMBRANE PROTEIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MICROSOMAL AMINOPEPTIDASE; PAPAIN; PEPSIN A; PEPTIDASE; PROTEINASE; PROTEINASE INHIBITOR; PROTIRELIN; RECOMBINANT ENZYME; SEPHADEX; SERINE PROTEINASE; TRICHLOROACETIC ACID; TRYPSIN; VIRUS ENZYME; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANNELID WORM; AQUEOUS SOLUTION; ARTICLE; BRAIN; BRAIN REGION; CHORDATA; COELENTERATE; CONTROLLED STUDY; CUBA; DRUG ACTIVITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; ECHINODERM; ENZYME ACTIVITY; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; HERMODICE CARUNCULATA; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOPHYSIS; HYPOTHALAMUS; IN VIVO STUDY; ION EXCHANGE CHROMATOGRAPHY; MALE; MOLECULAR WEIGHT; MOLLUSC; MOUSE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RODENT; SEASHORE; SPINAL CORD; SPONGE (PORIFERA); TOXICITY;

ANNELIDA; CHLOROPHYTA; CHORDATA; CNIDARIA; ECHINODERMATA; HERMODICE CARUNCULATA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INVERTEBRATA; MAGNOLIOPHYTA; MOLLUSCA; PORIFERA; RODENTIA;

EID: 0242317260     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00175-4     Document Type: Article

References (48)

1. Anson M.L. The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. Journal of General Physiology. 22:1938;79-84.
2. Bauer K. Purification and characterization of the thyrotropin-releasing hormone degrading ectoenzyme. European Journal of Biochemistry. 224:1994;387-396.
3. Bieth J.G. Theoretical and practical aspects of proteinase inhibition kinetics. Methods in Enzymology. 248:1995;59-84.
4. Buttery J.E., Stuart S. Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma. Clinical Chemistry. 39:1993;312-316.
5. Charli J.L., Méndez M., Vargas M.A., Cisneros M., Assai M., Joseph-Bravo P., Wilk S. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices. Neuropeptides. 14:1989;191-196.
6. Charli J.L., Vargas M.A., Cisneros M., de Gortari P., Baeza M.A., Jasso P., Bourdais J., Pérez L., Uribe R.M., Joseph-Bravo P. TRH inactivation in the extracellular compartment: Role of pyroglutamyl peptidase II. Neurobiology. 6:1998;45-57.
7. Delfin J., Morera V., González Y., Díaz J., Márquez M., Larionova N., Saroyán A., Padrón G., Chávez M. Purification, characterization and immobilization of proteinase inhibitors from Stichodactyla helianthus. Toxicon. 34:1996;1367-1376.
8. Elmore M.A., Griffiths E.C., O'Connor B., O'Cuinn G. Further characterization of the substrate specificity of a TRH hydrolyzing pyroglutamate aminopeptidase from guinea-pig brain. Neuropeptides. 15:1990;31-36.
9. Friedman T.C., Wilk S. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum. Biochemical and Biophysical Research Communications. 132:1985;787-794.
10. Friedman T.C., Wilk S. Delineation of a particulate thyrotropin- releasing hormone degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. Journal of Neurochemistry. 46:1986;1231-1239.
11. Fritz H., Brey B., Beress L. Polyvalent isoinhibitoren für trypsin, chymotrypsin, plasmin und kallikrein aus seeanemonen (Anemonia sulcata), isolierung, heimverhalten und aminosaurezusammensetzung. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie. 353:1972;19-30.
12. Garat B., Miranda J., Charli J.L., Joseph-Bravo P. Presence of a membrane bound pyroglutamyl aminopeptidase degrading thyrotropin releasing hormone in rat brain. Neuropeptides. 6:1985;27-40.
13. Geiger, R. (1984). Chymotrypsin. In J. Bergmeyer, M. Graßl (Eds.), Methods of enzymatic analysis (vol. 5, pp. 1984-1999). Weinheim: Verlag Chemie.
14. Gustafson G.L., Finn D.J., Moin K. Dissociation of proteinase-inhibitor complexes by trichloroacetate. Analytical Biochemistry. 169:1988;185-188.
15. Gutiérrez O.A., Salas E., Hernández Y., Lissi E.A., Castrillo G., Reyes O., Garay H., Aguilar A., García B., Otero A., Chavez M.A., Duarte C.A. An immunoenzymatic solid-phase assay for quantitative determination of HIV-1 protease activity. Analytical Biochemistry. 307:2002;18-24.
16. Hagel, L. (1989). Gel filtration, In J. C. Janson, & L. Ryden (Eds.), Protein Purification (pp. 63-106). New York: VCH.
17. Heuer H., Schäfer M.K-H., Bauer K. The thyrotropin-releasing hormone-degrading ectoenzyme: The third element of the thyrotropin-releasing hormone-signaling system. Thyroid. 8:1998;915-920.
18. Ikegami S., Kobayashi H., Myotoishi Y., Ohta S., Kato K.H. Selective inhibition of exoplasmic membrane fusion in echinoderm gametes with jaspisin, a novel antihatching substance isolated from a marine sponge. Journal of Biological Chemistry. 269:1994;23262-23267.
19. Joseph-Bravo P., Charli J.L., Palacios J.M., Kordon C. Effect of neurotransmitters on the in vitro release of immunoreactive thyrotropin releasing hormone from rat mediobasal hypothalamus. Endocrinology. 104:1979;801-806.
20. Kato K.H., Takemoto K., Kato E., Miyazaki K., Kobayashi H., Ikegami S. Inhibition of sea urchin fertilization by jaspisin, a specific inhibitor of matrix metalloendoproteinase. Development Growth and Differentiation. 40:1998;221-230.
21. Keeton T.P., Francis B.R., Maaty W.S., Bulla L.A. Jr. Effects of midgut-protein-preparative and ligand binding procedures on the toxin binding characteristics of BT-R1, a common high-affinity receptor in Manduca sexta for Cry1A Bacillus thuringiensis toxins. Applied and Environmental Microbiology. 64:1998;2158-2165.
22. Kelly J.A., Slator G.R., Tipton K.F., Williams C.H., Bauer K. Kinetic investigation of the specificity of porcine brain thyrotropin releasing hormone-degrading ectoenzyme for thyrotropin releasing hormone-like peptides. Journal of Biological Chemistry. 275:2000;16746-16751.
23. Kolkenbrock H., Tschesche H. A new inhibitor of elastase from the sea anemone Anemonia sulcata. Biological Chemistry Hoppe-Seyler. 368:1987;93-99.
24. La Barre S., Longeon A., Barthelemy M., Guyot M., Le Caer J.P., Bargibant G. Characterization of a novel elastase inhibitor from a fan coral. Comptes Rendus de l' Académie des Sciences Series, III. 319:1996;365-370.
25. Lenarcic B., Ritonja A., Strukelj B., Turk B., Turk V. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. Journal of Biological Chemistry. 272:1997;13899-13903.
26. Martin P., Raymond M.N., Bricas E., Dumas B.R. Kinetic studies on the action of Mucor pusillus, Mucor miehei acid proteases and chymosins A and B on a synthetic chromophoric hexapeptide. Biochimica et Biophysica Acta. 612:1980;410-420.
27. Masui Y., Takemoto T., Sakakibara S., Hori H., Nagai Y. Synthetic substrates for vertebrate collagenase. Biochemical Medicine. 17:1977;215-221.
28. Mebs D., Gebauer E. Isolation of proteinase inhibitory, toxic and hemolytic polypeptides from sea anemone Stoichactis sp. Toxicon. 18:1980;97-106.
29. Mock W.L., Stanford D.J. Arazoformyl dipeptide substrates for thermolysin. Confirmation of a reverse protonation catalytic mechanism. Biochemistry. 35:1996;7369-7377.
30. Nakajima K., Powers J.C., Ashe B.M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Journal of Biological Chemistry. 254:1979;4027-4032.
31. O'Connor B., O'Cuinn G. Localization of a narrow specificity thyroliberin hydrolyzing pyroglutamate aminopeptidase in synaptosomal membranes of guinea-pig brain. European Journal of Biochemistry. 144:1984;271-278.
32. O'Leary R.M., O'Connor B. Thyrotropin-releasing hormone. Journal of Neurochemistry. 65:1995;953-963.
33. Pardridge W.M. Blood-brain barrier biology and methodology. Journal of Neurovirology. 5:1999;556-569.
34. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analytical Biochemistry. 83:1977;346-356.
35. Roques B.P. Novel approaches to targeting neuropeptide systems. Trends in Pharmacological Sciences. 21:2000;475-483.
36. Schauder B., Schomburg L., Köhrle J., Bauer K. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin releasing hormone. Proceedings of the National Academy of Sciences (USA). 91:1994;9334-9538.
37. Scheitz H., Bruhn T., Guillemare E., Moinier D., Lancelin J.M., Beress L., Lazdunsky M. Kalicludines and Kaliseptines. Journal of Biological Chemistry. 270:1995;25121-25126.
38. Schmitmeier S., Thole H., Bader A., Bauer K. Purification and characterization of the thyrotropin-releasing hormone (TRH)-degrading serum enzyme and its identification as a product of liver origin. European Journal of Biochemistry. 269:2002;1278-1286.
39. Seelmeier S., Schmidt H., Turk V., von der Helm K. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proceedings of the National Academy of Sciences (USA). 85:1988;6612-6616.
40. Shishikura F., Abe T., Ohtake S., Tanaka K. Purification and characterization of a 58000-Da proteinase inhibitor from hemolynph of a solitary ascidian Holocynthia roretzi. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 114:1996;1-9.
41. Sjöström H., Norén O., Jeppesen L., Staun M., Svensson B., Christiansen L. Purification of different amphiphilic forms of a microvillus aminopeptidase from pig small intestine using immunoadsorbent chromatography. European Journal of Biochemistry. 88:1978;503-511.
42. Strukelj B., Lenarcic B., Gruden K., Pungercar J., Rogelj B., Turk V., Bosch D., Jongsma M.A. Equistatin, a protease inhibitor from the sea anemone Actinia equina, is composed of three structural and functional domains. Biochemical and Biophysical Research Communications. 269:2000;732-736.
43. Szewczuk A., Mulczyk M. Pyrrolidonil peptidase in bacteria. European Journal of Biochemistry. 8:1969;63-68.
44. Trautschold I.Y., Werle E. Spectrophotometric determination of kallikrein and its inactivators. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie. 325:1961;48-59.
45. Vargas M.A., Méndez M., Cisneros M., Joseph-Bravo P., Charli J.L. Regional distribution of the membrane bound pyroglutamate aminopeptidase degrading thyrotropin-releasing hormone in rat brain. Neuroscience Letters. 79:1987;311-314.
46. Wilk S., Wilk E.K. Pyroglutamyl peptidase II, a thyrotropin releasing hormone degrading enzyme: Purification and specificity studies of the rabbit brain enzyme. Neurochemistry International. 15:1989;81-90.
47. Wunderer, G., Beress, L., Machleidt, W., & Fritz, H. (1976). Broad specificity inhibitors from sea anemones. In L. Lorand (Ed.), Methods in Enzymology (vol. 45, pp. 881-888). New York: Academic Press.
48. Yoshimoto T., Walter R. Post-proline dipeptidyl aminopeptidase (dipeptidyl aminopeptidase IV) from lamb kidney. Purification and some enzymatic properties. Biochimica et Biophysica Acta. 485:1977;391-394.